C-reactive Protein Elevation Is Associated With QTc Interval Prolongation in Patients Hospitalized With COVID-19
Nino Isakadze1, Marc C Engels1, Dominik Beer1
1Division of Cardiology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, United States.
Frontiers in Cardiovascular Medicine
|July 11, 2022
Summary
Inflammation marker C-reactive protein (CRP) elevation is linked to corrected QT (QTc) interval prolongation in COVID-19 patients. Higher CRP levels correlated with longer QTc intervals, indicating a significant association.
Area of Science:
- Cardiology
- Infectious Diseases
- Clinical Medicine
Background:
- The link between inflammation and corrected QT (QTc) interval prolongation in COVID-19 is not well understood.
- Inflammatory markers may influence cardiac repolarization in COVID-19 patients.
Purpose of the Study:
- To investigate the association between C-reactive protein (CRP) levels and QTc interval duration in hospitalized COVID-19 patients.
- To determine if significant changes in CRP correlate with QTc interval changes during COVID-19 infection.
Main Methods:
- Retrospective cohort study of 85 adult COVID-19 patients with serial ECG and CRP measurements.
- Comparison of mean QTc intervals during high vs. low CRP levels.
- Mixed-effects linear regression to analyze CRP-QTc association.
Main Results:
- Mean QTc interval was 15 ms longer with high CRP levels (447 ms) compared to low CRP levels (432 ms).
- A 100 mg/L increase in CRP was associated with a 1.5 ms QTc increase (β=0.15, P<0.001).
- This association remained significant after adjusting for clinical and demographic factors (β=0.14, P<0.001).
Conclusions:
- Marked elevation in C-reactive protein levels is associated with corrected QT interval prolongation in COVID-19 patients.
- This finding highlights a potential link between systemic inflammation and cardiac electrical activity in COVID-19.
More Related Videos
Related Concept Videos
Myocarditis III: Medical Management
15
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
15
Acute Coronary Syndrome III: Diagnostic Studies
21
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
21
Electrocardiogram
3.2K
An electrocardiogram (ECG or EKG) is a critical diagnostic tool that records the electrical signals produced by the heart during each heartbeat. This recording is achieved through electrodes placed strategically on the arms, legs, and chest. The electrocardiograph amplifies these signals and produces 12 distinct tracings, offering a comprehensive understanding of the heart's electrical activity.
Three major waveforms are present in a typical ECG recording: the P wave, the QRS complex, and...
Three major waveforms are present in a typical ECG recording: the P wave, the QRS complex, and...
3.2K
Myocarditis II: Clinical Features and Diagnostic Tests
20
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
20
Acute Coronary Syndrome I: Introduction
70
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
70
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
43
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
43


